Date: 2017-04-25
Type of information: Collaboration agreement
Compound: library synthesis, medicinal chemistry and biological services
Company: European Molecular Biology Laboratory (EMBL) (Germany) Enamine (Ukraine)
Therapeutic area: Cancer - Oncology
Type agreement: collaboration
Action mechanism:
Disease:
Details: • On April 25, 2017, Enamine, a chemical company, producer of novel chemical building blocks and screening libraries, and the European Molecular Biology Laboratory (EMBL) have agreed to establish a collaboration whereby Enamine provides library synthesis, medicinal chemistry and biological services for the discovery and development of novel small molecules against EMBL’s proprietary anti-cancer targets. The collaboration involves the deployment of a team of Full Time Equivalent medicinal chemists at Enamine. This team will focus on the project’s multiple objectives towards creating new cancer therapeutics with novel modes of action.
Financial terms:
Latest news:
